IMMUNOHISTOCHEMISTRY CD138 Test
At DNA Labs UAE, we offer the IMMUNOHISTOCHEMISTRY CD138 test, a diagnostic test used in pathology to detect the presence of CD138 protein in tissue samples.
Test Details
The IMMUNOHISTOCHEMISTRY (IHC) CD138 test is a diagnostic test used in pathology to detect the presence of CD138 protein in tissue samples. CD138, also known as syndecan-1, is a cell surface proteoglycan that is expressed on plasma cells and some types of epithelial cells.
The IHC CD138 test involves the use of specific antibodies that bind to the CD138 protein in the tissue sample. These antibodies are usually labeled with a chromogen or fluorescent marker to visualize the presence of CD138.
The test is commonly used in the diagnosis and classification of multiple myeloma, a type of cancer that affects plasma cells. CD138 is a marker that is highly expressed on plasma cells, and its presence in tissue samples can help confirm the diagnosis of multiple myeloma.
In addition to multiple myeloma, the IHC CD138 test can also be used to detect CD138 expression in other diseases or conditions, such as plasma cell neoplasms, lymphomas, and certain types of carcinomas.
Test Components
The IMMUNOHISTOCHEMISTRY CD138 test is priced at 410.0 AED.
Sample Condition
To perform the test, please submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship the sample at room temperature. Please provide a copy of the Histopathology report, site of biopsy, and clinical history.
Report Delivery
The sample is processed daily, and the report is delivered by 6 pm. The report block is delivered within 5 days, tissue biopsy within 5 days, and tissue large complex within 7 days.
Method
The IMMUNOHISTOCHEMISTRY CD138 test is performed using immunohistochemistry, a method that involves the use of specific antibodies to detect the presence of CD138 protein in tissue samples.
Test Type
The IMMUNOHISTOCHEMISTRY CD138 test is used for the diagnosis of cancer.
Doctor
The test is typically ordered by an oncologist or pathologist.
Test Department
The IMMUNOHISTOCHEMISTRY CD138 test is conducted in the pathology department.
Pre Test Information
Prior to the test, please provide a copy of the Histopathology report, site of biopsy, and clinical history.
Conclusion
The IMMUNOHISTOCHEMISTRY CD138 test offered by DNA Labs UAE is a valuable tool in pathology for the detection and characterization of CD138 protein expression in tissue samples. It is particularly useful in the diagnosis of multiple myeloma and other related conditions. If you suspect the presence of CD138 protein in your tissue samples, contact DNA Labs UAE today for the IMMUNOHISTOCHEMISTRY CD138 test.
| Test Name | IMMUNOHISTOCHEMISTRY CD138 Test |
|---|---|
| Components | |
| Price | 410.0 AED |
| Sample Condition | Submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report, Site of biopsy and Clinical history. |
| Report Delivery | Sample Daily by 6 pm; Report Block: 5 days Tissue Biopsy: 5 days Tissue large complex : 7 days |
| Method | Immunohistochemistry |
| Test type | Cancer |
| Doctor | Oncologist, Pathologist |
| Test Department: | |
| Pre Test Information | Provide a copy of the Histopathology report, Site of biopsy and Clinical history. |
| Test Details | Immunohistochemistry (IHC) CD138 test is a diagnostic test used in pathology to detect the presence of CD138 protein in tissue samples. CD138, also known as syndecan-1, is a cell surface proteoglycan that is expressed on plasma cells and some types of epithelial cells. The IHC CD138 test involves the use of specific antibodies that bind to the CD138 protein in the tissue sample. These antibodies are usually labeled with a chromogen or fluorescent marker to visualize the presence of CD138. The test is commonly used in the diagnosis and classification of multiple myeloma, a type of cancer that affects plasma cells. CD138 is a marker that is highly expressed on plasma cells, and its presence in tissue samples can help confirm the diagnosis of multiple myeloma. In addition to multiple myeloma, the IHC CD138 test can also be used to detect CD138 expression in other diseases or conditions, such as plasma cell neoplasms, lymphomas, and certain types of carcinomas. The results of the IHC CD138 test are typically interpreted by a pathologist, who examines the stained tissue sample under a microscope. The presence or absence of CD138 staining in specific cells or tissues can provide valuable information for the diagnosis and management of various diseases. Overall, the IHC CD138 test is a useful tool in pathology for the detection and characterization of CD138 protein expression in tissue samples, particularly in the diagnosis of multiple myeloma and other related conditions. |
